Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey C Martin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Research Communications|November 7, 2022
WEE1 inhibition augments CDC7 (DDK) inhibitor-induced cell death in Ewing sarcoma by forcing premature mitotic entry and mitotic catastropheJeffrey C Martin, Jennie R Sims, Ajay Gupta, et al.
Molecular Cancer Research : MCR|October 6, 2020
Exploiting Replication Stress as a Novel Therapeutic InterventionJeffrey C Martin, Tamara J Hoegel, Miranda L Lynch, et al.
Scientific Reports|March 8, 2024
Aryl hydrocarbon receptor suppresses STING-mediated type I IFN expression in triple-negative breast cancerJeffrey C Martin, Tatiane da Silva Fernandes, Kanita A Chaudhry, et al.
Cell Death Discovery|February 27, 2022
CDC7 kinase (DDK) inhibition disrupts DNA replication leading to mitotic catastrophe in Ewing sarcomaJeffrey C Martin, Jennie R Sims, Ajay Gupta, et al.
Cold Spring Harbor Molecular Case Studies|November 25, 2021
Clinicopathologic and molecular analysis of a <i>BCOR-CCNB3</i> undifferentiated sarcoma of the kidney reveals significant epigenetic alterationsTamara J Hagoel, Eduardo Cortes Gomez, Ajay Gupta, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Scientific Reports|January 8, 2025
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancerTatiane da Silva Fernandes, Bryan M Gillard, Tao Dai, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Research Communications|November 7, 2022
WEE1 inhibition augments CDC7 (DDK) inhibitor-induced cell death in Ewing sarcoma by forcing premature mitotic entry and mitotic catastropheJeffrey C Martin, Jennie R Sims, Ajay Gupta, et al.
Molecular Cancer Research : MCR|October 6, 2020
Exploiting Replication Stress as a Novel Therapeutic InterventionJeffrey C Martin, Tamara J Hoegel, Miranda L Lynch, et al.
Scientific Reports|March 8, 2024
Aryl hydrocarbon receptor suppresses STING-mediated type I IFN expression in triple-negative breast cancerJeffrey C Martin, Tatiane da Silva Fernandes, Kanita A Chaudhry, et al.
Cell Death Discovery|February 27, 2022
CDC7 kinase (DDK) inhibition disrupts DNA replication leading to mitotic catastrophe in Ewing sarcomaJeffrey C Martin, Jennie R Sims, Ajay Gupta, et al.
Cold Spring Harbor Molecular Case Studies|November 25, 2021
Clinicopathologic and molecular analysis of a <i>BCOR-CCNB3</i> undifferentiated sarcoma of the kidney reveals significant epigenetic alterationsTamara J Hagoel, Eduardo Cortes Gomez, Ajay Gupta, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Scientific Reports|January 8, 2025
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancerTatiane da Silva Fernandes, Bryan M Gillard, Tao Dai, et al.
Pageof 1